References
- Atsumi S, Umezawa K, Iinuma H, Naganawa H, Nakamura H, Iitaka Y, Takeuchi T (1990): Production, isolation and structure determination of a novel beta-glucosidase inhibitor, cyclophellitol, from Phellinus sp. J Antibiot 43: 49–53.
- Baron AD (1998): Postprandial hyperglycaemia and alpha-glucosidase inhibitors. Diabetes Res Clin Pract 40: S51—S55.
- Collin M, Karlsson GB, James W, Butters TD, Davis SJ, Gordon S, Dwek RA, Platt FM (1995): The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immun-odeficiency virus entry at the level of post-CD4 binding. J Virol 69: 5791–5797.
- Fischer PB, Yamada H, Shiomi K, Xu Q, Nagai T, Shibata M, Oya I, Takahashi Y, Omura S (1995): New glycosidases inhibitors, panosialins D and wD produced by Streptomyces sp. OH-5186. J Antibiot 48: 205–210.
- Kim JG, Chang HB, Kwon YI, Moon SK, Chun HS, Alm SK, Hong CI (2002): Novel alpha-glucosidase inhibitors, CKD-711 and CKD-711a produced by Streptomyces sp. CK-4416. I. Taxonomy, fermentation and isolation. J Antibiot 55: 457–461.
- Kobayashi II, Tsuda M, Ishibashi M (1999): Bioactive products from marine micro- and macro-organisms. Pure Appl Chem 71: 1123–1126.
- Kurihara H, Sasaki M, Hatano M (1994): A new screening method for glucosidase inhibitors and its application to algal extracts. Fisheries Sci 60: 759–761.
- Kwon OS, Park SH, Yun BS, Pyun YR, Kim CJ (2001): Cyclo(D-Pro-L-Val), a specific beta-glucosidase inhibitor produced by Aspergillus sp. F70609. J Antibiot 54: 179–181.
- Mehta A, Zitzmann N, Rudd PM, Block TM, Dwek RA (1998): Alpha-glucosidase inhibitors as potential broad based anti-viral agents. FEBS Lett 430: 17–22.